Nicotine Science and Policy
By Harry Shapiro Aug. 13, 2026
Harry's blog 134: Filtering out lies and misinformation
The only major global journal focused on harm reduction has gone bust. Since 2017, Filter has advocated through journalism for rational and compassionate approaches to drug use, drug policy and human rights, while also standing out for its coverage of tobacco harm reduction. Its closure is a significant loss - particularly at a time when well-funded opponents of tobacco harm reduction continue to thrive.
October 16, 2026 by dcjournal.com
Counterpoint: A New Generation of the Same Old Mistake
Generational nicotine bans are gaining attention despite declining youth smoking and vaping rates in the United States. Critics argue that extending restrictions into adulthood could encourage illicit trade, limit consumer choice and undermine access to lower-risk nicotine products.
Experiences with tobacco prohibitions in Massachusetts and Bhutan illustrate the potential unintended consequences of restrictive policies. Protecting young people remains essential, but effective regulation should also recognise differences in product risk and preserve opportunities for adults to move away from combustible tobacco.
October 16, 2026 by planetofthevapes.co.uk
Strict Rules Keep Smokers Smoking
Daily smoking rates in Kazakhstan remain at 15%, compared with just 5.3% in Sweden, highlighting a significant difference in tobacco control outcomes. Kazakhstan has banned vapes and nicotine pouches, while Sweden has combined conventional tobacco control measures with access to regulated smoke-free alternatives.
According to Smoke Free Sweden’s Tale of Two Nations analysis, more than 17,000 tobacco-related deaths occur annually in Kazakhstan, and adopting a harm reduction approach could prevent up to 165,000 premature deaths over the next four decades. These projections underline the potential importance of risk-proportionate regulation, access to safer nicotine products and policies that support the transition away from combustible tobacco.
October 15, 2026 by smokefreesweden.org
Tale Of Two Nations – Vol. 15: Kazakhstan v Sweden
Sweden and Kazakhstan illustrate how different tobacco control strategies can shape smoking trends …
October 16, 2026 by snusforumet.se
Sweden's political deadlock leaves EU nicotine tax plans in limbo
Sweden’s political deadlock is now affecting the future of nicotine taxation across the EU. The October vote on the revised Tobacco Excise Directive has been postponed until November, while uncertainty over Sweden’s next government raises questions about whether an agreement can be reached.
At the centre of the disagreement is Sweden’s opposition to EU-wide tax rules that could treat nicotine pouches similarly to combustible tobacco. Sweden has argued for taxation that reflects differences in product risk, consistent with its tobacco harm reduction approach. The outcome could have significant implications for the affordability of smoke-free alternatives and the future direction of European nicotine policy.
October 15, 2026 by smokefreesweden.org
Tale Of Two Nations – Vol. 15: Kazakhstan v Sweden
Sweden and Kazakhstan illustrate how different tobacco control strategies can shape smoking trends and public health outcomes. Sweden has made significant progress in reducing smoking prevalence, supported by the availability of safer nicotine alternatives. Kazakhstan, meanwhile, has pursued a more restrictive approach to nicotine products, raising questions about the impact of limited access to smoke-free options.
The contrast highlights the importance of risk-proportionate regulation and the role consumer choice can play in reducing smoking-related harm.
October 15, 2026 by substack.com
Tobacco Risk Management: An Opportunity for Health Plans to Accelerate the Decline of Cigarette Smoking
Health insurers could play a much greater role in reducing smoking-related disease in the United States. Despite smoking cessation being among the most cost-effective medical interventions, fewer than half of smokers report receiving advice or assistance to quit.
Recent developments, including cheaper cessation medications, new clinical performance measures and growing evidence on safer nicotine alternatives, offer an opportunity to change that. Integrating tobacco harm reduction into health insurance programmes could improve patient outcomes while reducing long-term healthcare costs. The priority is not simply treating smoking-related disease, but investing in preventing it.
14.10% of the adult population are current smokers. There are approximately 39.8 million current smokers in United States 17.10% of men are current smokers but only 11.10% of women.
SOURCE: GSTHR
- Page 1 of 46
Blogs
Harry's blog 134: Filtering out lies and misinformation
The only major global journal focused on harm reduction has gone bust. Since 2017, Filter has advocated through journalism for rational and compassionate approaches to drug use, drug policy and human rights, while also standing out for its coverage of tobacco harm reduction. Its closure is a significant loss - particularly at a time when well-funded opponents of tobacco harm reduction continue to thrive.
Harry’s blog 133: Silence is consent
Two tobacco control consultations that demand your attention
I’m sure there are many of you like me who are deeply cynical about public consultations. They often feel like political tick box exercises allowing the issuing authority from local councils to international organisations to say they have ‘consulted with the people’, when in truth they knew exactly what they were going to do from the get-go.
Harry’s Blog 132: “Zyn! Went The Strings Of My Heart” (with apologies to Judy Garland)
FDA approval of 20 nicotine pouch products is another step forward for tobacco harm reduction
The FDA in the U.S. has granted marketing authorisation for Zyn nicotine pouch products (five variations on mint plus five other flavours in two different strengths).
In its letter to PMI (who own Zyn manufacturers Swedish Match), the FDA wrote:
Based on our review of your MRTPAs [Modified Risk Tobacco Applications] we determined that the proposed modified risk tobacco products, …as actually used by consumers would significantly reduce harm and the risk of tobacco-related disease to individual tobacco users and benefit the health of the population as a whole, taking into account both users of tobacco products and persons who do not currently use tobacco products. Therefore, we authorize marketing of the tobacco products as modified risk tobacco products with the following modified risk information – “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis”.